Stock Quote
King Pharmaceuticals, Inc. (KG.N) (New York Stock Exchange)
--
--
--
$12.08
--
--
--
--
$12.19
$5.86
0.80
3,293,369
KG.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Markison, Brian | Chairman of the Board, President, Chief Executive Officer | 6,966,230 |
| Squicciarino, Joseph | Chief Financial Officer | 3,292,510 |
| Bruce, Eric | President - Alpharma Animal Health | 1,895,620 |
Profile
King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products. It operates in four segments: branded prescription pharmaceuticals business, animal health business,... Full Description
Company Address
King Pharmaceuticals, Inc.
501 Fifth Street
Bristol TN 37620
P: +1423.9898000
F: +1423.2748677
501 Fifth Street
Bristol TN 37620
P: +1423.9898000
F: +1423.2748677
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Eli Lilly & Co. | $-- | -- |
| Phibro Animal Health Corporation | $5.23 | 0.00 |
| Novartis AG | CHF55.70 | -0.15 |
| KG.N | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.65 |
| P/S(TTM) | 1.78 | 0.57 |
| ROI(TTM) | -15.59 | 1.87 |
| ROE(TTM) | -18.89 | 2.53 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.25 |
| EPS Est. (Current Year) | 1.08 |
| Total Revenue | $463.35M |
| Net Income | $42.49M |
| EPS | $0.17 |
